| |
| |
|
| Insider
Information: |
Nanavaty Maulik |
| Relationship: |
|
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,758 |
|
|
Indirect Shares
|
11,017 |
|
|
| Direct
Value |
$13,668,364 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,775 |
|
|
| Total
Value |
$13,668,364 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• – – |
2012-02-24 |
4 |
D |
$6.25 |
$4,044 |
D/D |
(647) |
56,047 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-05-29 |
4 |
OE |
$6.28 |
$493,794 |
D/D |
71,558 |
206,092 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-08-30 |
4 |
OE |
$6.28 |
$243,455 |
D/D |
27,031 |
235,264 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$3,873 |
D/D |
(609) |
57,708 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-27 |
4 |
D |
$7.33 |
$17,130 |
D/D |
(2,337) |
74,852 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-24 |
4 |
D |
$7.37 |
$5,704 |
D/D |
(774) |
70,820 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$6,156 |
D/D |
(833) |
76,288 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-08-31 |
4 |
OE |
$7.39 |
$222,100 |
D/D |
30,000 |
238,233 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-08-29 |
4 |
OE |
$7.39 |
$251,519 |
D/D |
34,035 |
289,229 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-01-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
243,206 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-03-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
257,507 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-04-15 |
4 |
OE |
$7.41 |
$22,519 |
D/D |
3,039 |
257,508 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-05-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
257,507 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-06-17 |
4 |
OE |
$7.41 |
$22,519 |
D/D |
3,039 |
257,508 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-16 |
4 |
D |
$7.54 |
$7,005 |
D/D |
(929) |
69,485 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-12 |
4 |
D |
$7.59 |
$17,966 |
D/D |
(2,367) |
68,298 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-11-16 |
4 |
OE |
$8.30 |
$194,701 |
D/D |
23,458 |
256,809 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-02-09 |
4 |
OE |
$12.52 |
$194,911 |
D/D |
15,568 |
229,757 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-24 |
4 |
D |
$13.08 |
$93,666 |
D/D |
(7,161) |
93,582 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-10-03 |
4 |
OE |
$13.08 |
$125,869 |
D/D |
9,623 |
264,817 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-11-04 |
4 |
OE |
$13.08 |
$125,869 |
D/D |
9,623 |
264,817 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-12-04 |
4 |
OE |
$13.08 |
$125,869 |
D/D |
9,623 |
264,817 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-01-02 |
4 |
OE |
$13.08 |
$147,239 |
D/D |
9,623 |
269,842 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-28 |
4 |
D |
$13.10 |
$27,838 |
D/D |
(2,125) |
101,083 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$82,826 |
D/D |
(6,251) |
112,456 |
0 |
- |
|
176 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
